Hypothermic Oxygenated Perfusion

Bridge to Life Presents New ILTS 2026 Data Showing VitaSmart™ Hypothermic Oxygenated Perfusion (HOPE) Expands Use of Marginal Donor Livers and Preserves Mitochondrial Function for Real-Time Viability Assessment

FOR IMMEDIATE RELEASE Bridge to Life Presents New ILTS 2026 Data Showing VitaSmart™ Hypothermic Oxygenated Perfusion (HOPE) Expands Use of Marginal Donor Livers and Preserves Mitochondrial Function for Real-Time Viability Assessment Studies

Bridge to Life Ltd. Achieves Global Milestone in Liver Transplants Using Hypothermic Oxygenated Perfusion (HOPE) and VitaSmart™ System

Chicago, November 14, 2024 – Bridge to Life Ltd., a leading provider of organ preservation solutions and organ perfusion equipment, has announced that more than 5,0001 liver perfusions worldwide have

Portuguese Transplant Center Analysis of First 100 Cases of Hypothermic Oxygenated Perfusion (HOPE) in Liver Transplantation Demonstrates Increased Use of Marginal Grafts, Making More Livers Available for Transplantation

FOR IMMEDIATE RELEASE Analysis at ACS 2024 Highlights Benefits of Hypothermic Oxygenated Perfusion in Liver Transplantation San Francisco, California – October 21, 2024 – A compelling analysis involving 100 liver transplant cases